Conversion Strategy for LI-RADS Category 5 Observations across Versions 2014, 2017, and 2018

Stacy M Goins¹, Robert G Adamo¹, Eric Lam¹+6

• ¹From the Department of Radiology, Duke University School of Medicine, Durham, NC (S.M.G.); Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada (R.G.A.); The Ottawa Hospital Research Insitute, Clinical Epidemiology Program, Ottawa, ON, Canada (E.L., M.D.F.M.); Clinical Epidemiology Program (H.D.), and University of Ottawa Departments of Radiology and Epidemiology (M.D.F.M.), Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada (A.F.C.); Department of Diagnostic Radiology, Dalhousie University, Halifax, NS, Canada (A.F.C.); Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada (C.B.v.d.P.); Faculty of Health Sciences, Queen's University, Kingston, ON, Canada (J.P.S.); Departments of Radiology and Medicine and Center for Advanced Magnetic Resonance Development, Duke University Medical Center, 2301 Erwin Rd, Durham, NC 27701 (M.R.B.); and Department of Radiology, University of North Carolina, Chapel Hill, NC (M.R.B.).